Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
506 Leser
Artikel bewerten:
(2)

Jones Media Ltd: American Investor Files $16 Million Lawsuit Against Turks and Caicos Government Over Broken Promises and Business Damages

Finanznachrichten News

The lawsuit, which was prominently featured in the August 16th edition of The Turks and Caicos Sun, the largest newspaper in the region, highlights the challenges faced by foreign investors in the Turks and Caicos Islands under the current administration.

PROVIDENCIALES, TURKS AND CAICOS / ACCESSWIRE / August 23, 2024 / Rick Langley, a prominent American entrepreneur and philanthropist, has filed a $16 million lawsuit against the Turks and Caicos Islands Government (TCIG), alleging that broken promises and bureaucratic hurdles have caused significant financial harm to his business ventures in the islands.

TCI Sun Cover Page

TCI Sun Cover Page
American Investor Files $16 Million Lawsuit Against Turks and Caicos Government

The lawsuit, which was prominently featured in the August 16th edition of The Turks and Caicos Sun, the largest newspaper in the region, highlights the challenges faced by foreign investors in the Turks and Caicos Islands under the current administration. According to Langley, previous commitments made by the People's Democratic Movement (PDM) administration, which facilitated his business activities, were subsequently disregarded by the new government, leading to severe financial losses.

Langley, widely known for his venture in the health and beauty industry, specifically targeted the bureaucratic roadblocks that have prevented him from importing his key product-scorpions used in a unique Blue Scorpion Peptide product. Despite initial assurances, Langley claims that the new government has failed to provide the necessary permits and has delayed responses over three years, effectively stalling his business operations.

In an exclusive interview with The Turks and Caicos Sun, Langley expressed his deep disappointment, stating, "The government destroyed my dreams, my career, and my finances." He emphasized the significant impact of the government's actions, not only on his business but also on the local economy, which had expected job creation and revenue generation from his ventures.

Langley's legal action seeks to recover the $16 million in damages he claims to have incurred due to the government's failure to honor previous commitments. He also raised concerns about the broader implications for foreign investment in the Turks and Caicos Islands, warning that the current climate could deter future investors.

The full article detailing Langley's claims and the ongoing legal battle can be found in the latest edition of The Turks and Caicos Sun. A high-resolution image of the article is available upon request.

For further information please contact:

Oliver Jones
Jones Media, Ltd.
ojonesmedialtd@gmail.com
310.433.8289

About Rick Langley

Rick Langley is an entrepreneur and philanthropist known for his innovative approach in the health and beauty sector. He has made significant contributions to the industry through the development of unique products and has a history of successful business ventures in various regions.

Contact Information

Oliver Jones
President
ojonesmedialtd@gmail.com
3104338289

SOURCE: Rick Langley

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.